[go: up one dir, main page]

AU2002211176A1 - Composition comprising serotonin receptor antagonists, 5 ht-2 and 5 ht-3 - Google Patents

Composition comprising serotonin receptor antagonists, 5 ht-2 and 5 ht-3

Info

Publication number
AU2002211176A1
AU2002211176A1 AU2002211176A AU1117602A AU2002211176A1 AU 2002211176 A1 AU2002211176 A1 AU 2002211176A1 AU 2002211176 A AU2002211176 A AU 2002211176A AU 1117602 A AU1117602 A AU 1117602A AU 2002211176 A1 AU2002211176 A1 AU 2002211176A1
Authority
AU
Australia
Prior art keywords
composition
receptor antagonists
serotonin receptor
serotonin
antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2002211176A
Inventor
Staffan Skogvall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Respiratorius AB
Original Assignee
Respiratorius AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0003996A external-priority patent/SE0003996D0/en
Application filed by Respiratorius AB filed Critical Respiratorius AB
Publication of AU2002211176A1 publication Critical patent/AU2002211176A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002211176A 2000-11-01 2001-10-30 Composition comprising serotonin receptor antagonists, 5 ht-2 and 5 ht-3 Withdrawn AU2002211176A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24466200P 2000-11-01 2000-11-01
US60244662 2000-11-01
SE0003996 2000-11-01
SE0003996A SE0003996D0 (en) 2000-11-01 2000-11-01 receptor Antagonists
PCT/SE2001/002373 WO2002036114A1 (en) 2000-11-01 2001-10-30 Composition comprising serotonin receptor antagonists, 5 ht-2 and 5 ht-3

Publications (1)

Publication Number Publication Date
AU2002211176A1 true AU2002211176A1 (en) 2002-05-15

Family

ID=26655285

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002211176A Withdrawn AU2002211176A1 (en) 2000-11-01 2001-10-30 Composition comprising serotonin receptor antagonists, 5 ht-2 and 5 ht-3

Country Status (2)

Country Link
AU (1) AU2002211176A1 (en)
WO (1) WO2002036114A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL210065B1 (en) 2002-09-25 2011-11-30 Memory Pharm Corp Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
EP1697378B1 (en) 2003-12-22 2007-11-21 Memory Pharmaceuticals Corporation Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
CA2558126A1 (en) * 2004-03-17 2005-09-29 Sosei R&D Ltd. The treatment of inflammatory disorders and pain using beta-aminoalcohols
EP1735306A2 (en) 2004-03-25 2006-12-27 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
EP1742944B1 (en) 2004-04-22 2010-11-10 Memory Pharmaceuticals Corporation Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof
KR20070015607A (en) 2004-05-07 2007-02-05 메모리 파마슈티칼스 코포레이션 1H-indazole, benzothiazole, 1,2-benzoisoxazole, 1,2-benzoisothiazole, and chromone and preparation and use thereof
US20060069124A1 (en) * 2004-09-07 2006-03-30 Rao P S Use of MDL-100,907 for treatment of allergic and eosinophil mediated diseases
ATE455776T1 (en) 2004-12-22 2010-02-15 Memory Pharm Corp NICOTINIC ALPHA-7 RECEPTOR LIGANDS AGAINST CNS DISEASES
WO2007000046A1 (en) * 2005-06-27 2007-01-04 Holburn Biomedical Corporation Methods for diagnosing functional bowel disease
US8106066B2 (en) 2005-09-23 2012-01-31 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
GB0901487D0 (en) * 2009-01-30 2009-03-11 Movetis N V Asthma Therapy
WO2014018563A2 (en) * 2012-07-23 2014-01-30 The Board Of Trustees Of The Leland Stanford Junior University Methods for the treatment of cancer
US11045454B2 (en) 2018-12-06 2021-06-29 Palo Alto Investors LP Methods of treating food allergy conditions
CN110776454B (en) * 2019-12-10 2021-03-23 马宏跃 Synthesis method of bufotenine and quaternary ammonium salt thereof and application of bufotenine and quaternary ammonium salt thereof in preparation of analgesic and anti-inflammatory drugs
PH12022553135A1 (en) 2020-05-19 2024-03-04 Cybin Irl Ltd Deuterated tryptamine derivatives and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of a drug by a serotonin 1A receptor antagonist
US6331536B1 (en) * 1998-02-27 2001-12-18 The Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
EP1173168A2 (en) * 1999-04-28 2002-01-23 Respiratorius AB Compound for use as a medicament for treatment of disorders involving bronchocontraction
GB9918425D0 (en) * 1999-08-04 1999-10-06 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
WO2002036114A1 (en) 2002-05-10

Similar Documents

Publication Publication Date Title
AU4552099A (en) Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5HT2 receptors
PL366233A1 (en) Substituted pyridoindoles as serotonin agonists and antagonists
MXPA02007289A (en) Novel melanocortin receptor agonists and antagonists.
AU2002347022A1 (en) Benzimidazols and indols as glucagon receptor antagonists/inverse agonisten
AU2001243345A1 (en) 1983, 52881, 2398, 45449, 50289, and 52872, g protein-coupled receptors and uses therefor
AU2002211176A1 (en) Composition comprising serotonin receptor antagonists, 5 ht-2 and 5 ht-3
MXPA03005257A (en) Nmda receptor agonist pharmaceutical compositions.
AU2002235224A1 (en) Muscarinic antagonists
AU2002223501A1 (en) Glucagon antagonists/inverse agonists
AU4217299A (en) Pth1r and pth3r receptors, methods and uses thereof
AU2001264657A1 (en) Crf receptor antagonists
AU2002223500A1 (en) Glucagon antagonists/inverse agonists
ZA200100978B (en) Muscarinic agonists and antagonists.
AU2002212888A1 (en) Composition comprising: serotonin receptor antagonists (5ht-2, 5ht-3) and agonist (5ht-4)
AU2001225663A1 (en) A composition comprising a combination of receptor agonists and antagonists
AUPP380498A0 (en) Egf receptor agonists and antagonists
HUP0300419A3 (en) Estrogen agonist/antagonist metabolites, pharmaceutical compositions containing them and their use
AU2001290772A1 (en) Alpha v integrin receptor antagonists
GB0026467D0 (en) Compound, composition and use
AU2001286409A1 (en) N-methyl-d-aspartate receptor antagonists
HUP0100926A3 (en) Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d4 receptor antagonists
AU1652601A (en) New combination comprising a beta2-adrenoreceptor agonist and a leukotriene receptor antagonist
AU8177801A (en) 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists
AU2002226048A1 (en) Urotensin-ii receptor antagonists
AU2002216079A1 (en) Bombesin receptor antagonists